Stanford's Karen Parker explains why low brain vasopressin may be a biomarker and treatment target for autism's social deficits.

Karen Parker: Stanford School of Medicine professor who directs the Social Neurosciences Research Program, studying the biological basis of social functioning across the lifespan. Her lab focuses on autism, primate models, and the neuropeptides oxytocin and vasopressin.
Andrew Huberman and Dr. Karen Parker discuss the causes, diagnosis, and emerging treatments for autism. They examine why autism rates have risen to roughly 1 in 36 US children, the genetic and environmental contributors, and the difficulty of diagnosing a heterogeneous behavioral condition. Parker walks through her research on the neuropeptides oxytocin and vasopressin, including a primate model of natural social impairment she validated in rhesus macaques. The centerpiece is her discovery that low cerebrospinal-fluid vasopressin tracks social deficits in monkeys, in children with autism, and even in infants who are later diagnosed, and that intranasal vasopressin improved social abilities in a small pilot trial. They also cover oxytocin trials, the gut microbiome-vagus nerve connection, a failed pharmaceutical trial that used the opposite (antagonist) approach, and the debunked vaccine-autism claim.
Netflix
“the Netflix show chimp Empire people haven't seen it they should watch it when you watch it you realize they're very much like us”— Karen Parker
Barry Levinson
“it was actually where um Dustin Hoffman went to um study for his role in Rainman and the uh the kids who were really delightful”— Andrew Huberman
GlaxoSmithKline
“ssris or atypical anti-depressants like Ryon Wellbutrin and things of that sort when they work they probably work because of their ability to induce neuroplasticity”— Andrew Huberman
Teva Pharmaceuticals
“things like adderal viance even methylphenidate rlin I mean these are amphetamines they induce dopamine release and norepinephrine release”— Andrew Huberman
Takeda
“things like adderal viance even methylphenidate rlin I mean these are amphetamines they induce dopamine release and norepinephrine release”— Andrew Huberman
Novartis
“things like adderal viance even methylphenidate rlin I mean these are amphetamines they induce dopamine release and norepinephrine release”— Andrew Huberman